118 related articles for article (PubMed ID: 12694657)
1. Clinical significance of interleukin-1 receptor antagonist in patients with cervical carcinoma.
Fujiwaki R; Iida K; Nakayama K; Kanasaki H; Hata K; Katabuchi H; Okamura H; Miyazaki K
Gynecol Oncol; 2003 Apr; 89(1):77-83. PubMed ID: 12694657
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of serum CA-125 and soluble tumor necrosis factor receptor type I in cervical adenocarcinoma patients.
Kotowicz B; Kaminska J; Fuksiewicz M; Kowalska M; Jonska-Gmyrek J; Gawrychowski K; Sobotkowski J; Skrzypczak M; Starzewski J; Bidzinski M
Int J Gynecol Cancer; 2010 May; 20(4):588-92. PubMed ID: 20686378
[TBL] [Abstract][Full Text] [Related]
3. Altered expression of interleukin-1 receptor antagonist in different stages of mouse skin carcinogenesis.
La E; Muga SJ; Locniskar MF; Fischer SM
Mol Carcinog; 1999 Apr; 24(4):276-86. PubMed ID: 10326864
[TBL] [Abstract][Full Text] [Related]
4. [Clinical significance of serum squamous cell carcinoma antigen in patients with early cervical squamous cell carcinoma].
Li D; Xu XX; Yan DD; Yuan SH; Lou HM
Zhonghua Zhong Liu Za Zhi; 2019 May; 41(5):357-362. PubMed ID: 31137169
[No Abstract] [Full Text] [Related]
5. [Expression of aquaporin-8 and bcl-2 protein in human cervical carcinoma and their correlations].
Yao JF; Zhou CY; Wei LF; Wang SY; Shi YF
Zhonghua Fu Chan Ke Za Zhi; 2008 Mar; 43(3):205-8. PubMed ID: 18788571
[TBL] [Abstract][Full Text] [Related]
6. The clinicopathologic significance of laminin-5 gamma2 chain expression in cervical squamous carcinoma and adenocarcinoma.
Andersson S; Hellström AC; Angström T; Stendahl U; Auer G; Wallin KL
Int J Gynecol Cancer; 2005; 15(6):1065-72. PubMed ID: 16343183
[TBL] [Abstract][Full Text] [Related]
7. LRIG2 in contrast to LRIG1 predicts poor survival in early-stage squamous cell carcinoma of the uterine cervix.
Hedman H; Lindström AK; Tot T; Stendahl U; Henriksson R; Hellberg D
Acta Oncol; 2010 Aug; 49(6):812-5. PubMed ID: 20553099
[TBL] [Abstract][Full Text] [Related]
8. Special AT-rich sequence-binding protein 1: a novel biomarker predicting cervical squamous cell carcinoma prognosis and lymph node metastasis.
Wang S; Wang L; Zhang Y; Liu Y; Meng F; Ma J; Shang P; Gao Y; Huang Q; Chen X
Jpn J Clin Oncol; 2015 Sep; 45(9):812-8. PubMed ID: 26117495
[TBL] [Abstract][Full Text] [Related]
9. Serum vascular endothelial growth factor (VEGF) and VEGF-C levels as tumor markers in patients with cervical carcinoma.
Mitsuhashi A; Suzuka K; Yamazawa K; Matsui H; Seki K; Sekiya S
Cancer; 2005 Feb; 103(4):724-30. PubMed ID: 15637689
[TBL] [Abstract][Full Text] [Related]
10. Interleukin 1 receptor antagonist (IL-1RA) polymorphism in women with cervical cancer.
Mustea A; Sehouli J; Könsgen D; Stengel D; Sofroni D; Lichtenegger W
Anticancer Res; 2003; 23(2A):1099-102. PubMed ID: 12820354
[TBL] [Abstract][Full Text] [Related]
11. Abnormal IL-1 receptor antagonist production in patients with polymyositis and dermatomyositis.
Son K; Tomita Y; Shimizu T; Nishinarita S; Sawada S; Horie T
Intern Med; 2000 Feb; 39(2):128-35. PubMed ID: 10732829
[TBL] [Abstract][Full Text] [Related]
12. [Expressions of bFGF and PTEN in cervical carcinoma and their clinical significance].
Luo CF; Hong HL; Lu YL; Wang H; Liu MQ
Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):533-8. PubMed ID: 21029699
[TBL] [Abstract][Full Text] [Related]
13. Plasma levels of interleukin-1 receptor antagonist (IL-1ra) and severity of illness in patients with burns.
Endo S; Inada K; Yamada Y; Kasai T; Takakuwa T; Nakae H; Kamei Y; Shimamura T; Suzuki T; Taniguchi S; Yoshida M
J Med; 1996; 27(1-2):57-71. PubMed ID: 8863178
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of p53 expression in early stage cervical carcinoma treated by surgery.
Khunamornpong S; Siriaunkgul S; Manusirivithaya S; Settakorn J; Srisomboon J; Ponjaroen J; Thorner PS
Asian Pac J Cancer Prev; 2008; 9(1):48-52. PubMed ID: 18439073
[TBL] [Abstract][Full Text] [Related]
15. Significance of PTPRZ1 and CIN85 expression in cervical carcinoma.
Ma Y; Ye F; Xie X; Zhou C; Lu W
Arch Gynecol Obstet; 2011 Sep; 284(3):699-704. PubMed ID: 20882291
[TBL] [Abstract][Full Text] [Related]
16. Research on expression and importance of p53, p16 and VEGF-C in cervical cancer.
Cai S; Han K
J Gynecol Obstet Biol Reprod (Paris); 2015 Sep; 44(7):639-45. PubMed ID: 25443468
[TBL] [Abstract][Full Text] [Related]
17. Combined detection of Twist1, Snail1 and squamous cell carcinoma antigen for the prognostic evaluation of invasion and metastasis in cervical squamous cell carcinoma.
Yang H; Hu H; Gou Y; Hu Y; Li H; Zhao H; Wang B; Li P; Zhang Z
Int J Clin Oncol; 2018 Apr; 23(2):321-328. PubMed ID: 29101499
[TBL] [Abstract][Full Text] [Related]
18. Profile of circulating levels of interleukin-1 receptor antagonist and interleukin-6 in colorectal cancer patients.
Ito H; Miki C
Scand J Gastroenterol; 1999 Nov; 34(11):1139-43. PubMed ID: 10582766
[TBL] [Abstract][Full Text] [Related]
19. Impact of polymorphism in IL-1RA gene on the risk of cervical cancer.
Tamandani DM; Sobti RC; Shekari M; Kaur S; Huria A
Arch Gynecol Obstet; 2008 Jun; 277(6):527-33. PubMed ID: 18008080
[TBL] [Abstract][Full Text] [Related]
20. [Expression of COX-2 and MMP-9 in cervical carcinoma and their clinical significance].
Luo CF; Zhu RQ; Wang H; Lu YL
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):526-30. PubMed ID: 18069634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
